2014
DOI: 10.1111/imj.12337
|View full text |Cite
|
Sign up to set email alerts
|

Stroke thrombolysis: per ardua, ad astra

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…Accurate times of the onset of symptoms were poorly described on the ePCRs making it difficult to assess the 3-hour time window. Patients whose time of onset is unknown cannot have thrombolysis due to the uncertainty of whether they are within the treatment time-window (3,38). The majority of patients were transported as high priority and most patients were transported to a hospital with an acute stroke care service.…”
Section: Discussionmentioning
confidence: 99%
“…Accurate times of the onset of symptoms were poorly described on the ePCRs making it difficult to assess the 3-hour time window. Patients whose time of onset is unknown cannot have thrombolysis due to the uncertainty of whether they are within the treatment time-window (3,38). The majority of patients were transported as high priority and most patients were transported to a hospital with an acute stroke care service.…”
Section: Discussionmentioning
confidence: 99%
“…The recent editorial by Bladin mentions controversy about stroke thrombolysis but fails to address it. 1 Stroke is indeed a 'complex and heterogeneous disease' but the statement that it 'defies containment within the context of traditional research methodologies' indicates we may have given up trying to determine properly whether thrombolysis really works. We argue that the complexity of stroke makes the pursuit of high-quality evidence more essential, something that has not been achieved to date for this subject.…”
Section: General Correspondencementioning
confidence: 99%
“…Expertise is needed due to a possible misdiagnosis of stroke mimics and a potential risk of intracerebral haemorrhage if administered to patients who are inappropriate for the treatment . Although recent meta‐analytic work illustrates the effectiveness of rt‐PA regardless of age and stroke severity and its cost‐effectiveness, this treatment is not without controversy . For example, in the statement on intravenous thrombolysis for ischaemic stroke (updated March 2014), The Australian College of Emergency Medicine states that ‘it cannot currently be considered a “standard of care” ’.…”
Section: Introductionmentioning
confidence: 99%
“…3 Although recent metaanalytic work illustrates the effectiveness of rt-PA regardless of age and stroke severity 5 and its cost-effectiveness, 6 this treatment is not without controversy. [7][8][9][10][11][12][13] For example, in the statement on intravenous thrombolysis for ischaemic stroke 7 (updated March 2014), The Australian College of Emergency Medicine states that 'it cannot currently be considered a "standard of care" '. In turn, however, Fitzgerald and Gerraty 14 indicated that 'A coordinated system of care for stroke and transient ischaemic attack in Australia has been stalled by the lack of a concerted effort to adopt thrombolysis'.…”
Section: Introductionmentioning
confidence: 99%